ANGES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49 JPY | -2.00% |
|
-2.00% | -31.94% |
| Sales 2022 | 67M 433K | Sales 2023 | 152M 982K | Capitalization | 14.23B 91.89M |
|---|---|---|---|---|---|
| Net income 2022 | -14.71B -95.02M | Net income 2023 | -7.44B -48.03M | EV / Sales 2022 | 165 x |
| Net cash position 2022 | 9.88B 63.81M | Net cash position 2023 | 3.8B 24.53M | EV / Sales 2023 | 68.6 x |
| P/E ratio 2022 |
-1.29
x | P/E ratio 2023 |
-1.83
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.87% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -2.00% | ||
| 1 week | -2.00% | ||
| Current month | -25.76% | ||
| 1 month | -28.99% | ||
| 3 months | -31.94% | ||
| 6 months | -40.96% | ||
| Current year | -31.94% |
1 week
49.00
55.00
1 month
49.0070.00
Current year
49.0092.00
1 year
49.00143.00
3 years
49.001 060.00
5 years
49.002 492.00
10 years
49.002 492.00
| Managers | Title | Age | Since |
|---|---|---|---|
Tetsuji Yoneo
DFI | Director of Finance/CFO | 54 | 12-09-30 |
Ei Yamada
PSD | President | 73 | 01-04-30 |
Kazuo Suzuki
CTO | Chief Tech/Sci/R&D Officer | 67 | 19-01-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ei Yamada
PSD | President | 73 | 01-04-30 |
Makoto Hara
BRD | Director/Board Member | 73 | 18-03-28 |
Junichi Komamura
BRD | Director/Board Member | 73 | 12-02-29 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 49 | -2.00% | 1 598 600 |
| 24-04-22 | 50 | 0.00% | 1,456,800 |
| 24-04-19 | 50 | -1.96% | 2,230,900 |
| 24-04-18 | 51 | 0.00% | 4,780,700 |
| 24-04-17 | 51 | +2.00% | 1,273,400 |
Delayed Quote Japan Exchange, April 23, 2024 at 02:00 am EDT
More quotes
AnGes, Inc., formerly AnGes MG, Inc., is a Japan-based company mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidated subsidiaries. On January 31, 2013, the Company sold a 95.3% stake of a Osaka-based subsidiary to ISHIHARA SANGYO KAISHA LTD.
Calendar
2024-05-09
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -31.94% | 65.01M | |
| +2.49% | 96.73B | |
| -0.20% | 21.31B | |
| -16.61% | 21.21B | |
| -5.48% | 18.79B | |
| -42.14% | 16.37B | |
| -27.40% | 13.68B | |
| +1.44% | 13.44B | |
| +21.29% | 10.98B | |
| -21.79% | 8.56B |
- Stock Market
- Equities
- 4563 Stock
